This is the authors' abstract. We don't add key points for this paper.
We studied seroprevalence and concentrations of Epstein-Barr virus (EBV) antibodies in 147 pediatric patients with multiple sclerosis (MS) and paired controls. The children with MS showed a near-complete seropositivity for EBV antibody against virus capsid antigen (98.6% vs 72.1% in controls, p = 0.001) but did not display serologic evidence for a recent EBV infection. EBV antibody concentrations of pediatric patients with MS were significantly higher vs controls.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pohl et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: